Results: 1-25 | 26-50 | 51-63
Results: 1-25/63

Authors: Xie, CS Lovell, MA Xiong, SL Kindy, MS Guo, JT Xie, J Amaranth, V Montine, TJ Markesbery, WR
Citation: Cs. Xie et al., Expression of glutathione-S-transferase isozyme in the SY5Y neuroblastoma cell, line increases resistance to oxidative stress, FREE RAD B, 31(1), 2001, pp. 73-81

Authors: Aksenov, MY Aksenova, MV Butterfield, DA Geddes, JW Markesbery, WR
Citation: My. Aksenov et al., Protein oxidation in the brain in Alzheimer's disease, NEUROSCIENC, 103(2), 2001, pp. 373-383

Authors: Aksenov, MY Markesbery, WR
Citation: My. Aksenov et Wr. Markesbery, Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease, NEUROSCI L, 302(2-3), 2001, pp. 141-145

Authors: Robertson, JD Lovell, MA Buchholz, B Xie, CS Markesbery, WR
Citation: Jd. Robertson et al., Use of bomb pulse C-14 to age senile plaques and neurofibrillary tangles in the Alzheimer's disease brain, J RAD NUCL, 249(2), 2001, pp. 443-447

Authors: Lovell, MA Xie, CS Markesbery, WR
Citation: Ma. Lovell et al., Acrolein is increased in Alzheimer's disease brain and is toxic to primaryhippocampal cultures, NEUROBIOL A, 22(2), 2001, pp. 187-194

Authors: Gosche, KM Mortimer, JA Smith, CD Markesbery, WR Snowdon, DA
Citation: Km. Gosche et al., An automated technique for measuring hippocampal volumes from MR imaging studies, AM J NEUROR, 22(9), 2001, pp. 1686-1689

Authors: Petrovitch, H White, LR Ross, GW Steinhorn, SC Li, CY Masaki, KH Davis, DG Nelson, J Hardman, J Curb, JD Blanchette, PL Launer, LJ Yano, K Markesbery, WR
Citation: H. Petrovitch et al., Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study, NEUROLOGY, 57(2), 2001, pp. 226-234

Authors: Picklo, MJ Olson, SJ Markesbery, WR Montine, TJ
Citation: Mj. Picklo et al., Expression and activities of aldo-keto oxidoreductases in Alzheimer disease, J NE EXP NE, 60(7), 2001, pp. 686-695

Authors: Lauderback, CM Hackett, JM Huang, FF Keller, JN Szweda, LI Markesbery, WR Butterfield, DA
Citation: Cm. Lauderback et al., The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of A beta 1-42, J NEUROCHEM, 78(2), 2001, pp. 413-416

Authors: Schmitt, FA Wetherby, MMC Wekstein, DR Dearth, CMS Markesbery, WR
Citation: Fa. Schmitt et al., Brain donation in normal aging: Procedures, motivations, and donor characteristics from the biologically resilient adults in neurological studies (BRAiNS) project, GERONTOLOGI, 41(6), 2001, pp. 716-722

Authors: Picklo, MJ Olson, SJ Hayes, JD Markesbery, WR Montine, TJ
Citation: Mj. Picklo et al., Elevation of AKR7A2 (succinic semialdehyde reductase) in neurodegenerativedisease, BRAIN RES, 916(1-2), 2001, pp. 229-238

Authors: Lauderback, CM Hackett, JM Keller, JN Varadarajan, S Szweda, L Kindy, M Markesbery, WR Butterfield, DA
Citation: Cm. Lauderback et al., Vulnerability of synaptosomes from ApoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): Implications for Alzheimer's disease, BIOCHEM, 40(8), 2001, pp. 2548-2554

Authors: Lovell, MA Markesbery, WR
Citation: Ma. Lovell et Wr. Markesbery, Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid, ARCH NEUROL, 58(3), 2001, pp. 392-396

Authors: Reich, EE Markesbery, WR Roberts, LJ Swift, LL Morrow, JD Montine, TJ
Citation: Ee. Reich et al., Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease, AM J PATH, 158(1), 2001, pp. 293-297

Authors: Wackerbarth, SB Johnson, MMS Markesbery, WR Smith, CD
Citation: Sb. Wackerbarth et al., Urban-rural differences in a memory disorders clinical population, J AM GER SO, 49(5), 2001, pp. 647-650

Authors: Markesbery, WR Montine, TJ Lovell, MA
Citation: Wr. Markesbery et al., Oxidative alterations in neurodegenerative diseases, CONT NEUROS, 2001, pp. 21-51

Authors: Markesbery, WR
Citation: Wr. Markesbery, Overview of vascular dementia, ALZHEIMER'S DISEASE, 2001, pp. 205-218

Authors: Smith, CD Snowdon, D Markesbery, WR
Citation: Cd. Smith et al., Periventricular white matter hyperintensities on MRI: Correlation with neuropathologic findings, J NEUROIMAG, 10(1), 2000, pp. 13-16

Authors: Lovell, MA Xie, CS Markesbery, WR
Citation: Ma. Lovell et al., Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures, FREE RAD B, 29(8), 2000, pp. 714-720

Authors: Xie, CS Markesbery, WR Lovell, MA
Citation: Cs. Xie et al., Survival of hippocampal and cortical neurons in a mixture of MEM+ and B27-supplemented neurobasal medium, FREE RAD B, 28(5), 2000, pp. 665-672

Authors: Lovell, MA Xie, CS Gabbita, SP Markesbery, WR
Citation: Ma. Lovell et al., Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain, FREE RAD B, 28(3), 2000, pp. 418-427

Authors: Keller, JN Markesbery, WR
Citation: Jn. Keller et Wr. Markesbery, Proteasome inhibition results in increased poly-ADP-ribosylation: Implications for neuron death, J NEUROSC R, 61(4), 2000, pp. 436-442

Authors: Keller, JN Huang, FF Markesbery, WR
Citation: Jn. Keller et al., Decreased levels of proteasome activity and proteasome expression in agingspinal cord, NEUROSCIENC, 98(1), 2000, pp. 149-156

Authors: Rulon, LL Robertson, JD Lovell, MA Deibel, MA Ehmann, WD Markesbery, WR
Citation: Ll. Rulon et al., Serum zinc levels and Alzheimer's disease, BIOL TR EL, 75(1-3), 2000, pp. 79-85

Authors: Keller, JN Hanni, KB Markesbery, WR
Citation: Jn. Keller et al., Possible involvement of proteasome inhibition in aging: implications for oxidative stress, MECH AGE D, 113(1), 2000, pp. 61-70
Risultati: 1-25 | 26-50 | 51-63